Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers for neuromyelitis optica
Kuo‐Hsuan Chang, Long‐Sun Ro, Rong‐Kuo Lyu, et al.
Clinica Chimica Acta (2014) Vol. 440, pp. 64-71
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: the first report
Yoshitsugu Narumi, Ryohei Yoshida, Yoshinori Minami, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 54
Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica
Zhen Wang, Yaping Yan
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 51
Soluble TREM2 triggers microglial dysfunction in neuromyelitis optica spectrum disorders
Chuanbo Qin, Man Chen, Minghao Dong, et al.
Brain (2023) Vol. 147, Iss. 1, pp. 163-176
Closed Access | Times Cited: 16
Distinguishing Neuromyelitis Optica Spectrum Disorders Subtypes: A Study on AQP4 and C3d Epitope Expression in Cytokine‐Primed Human Astrocytes
Marlen Alisch, Franziska Foersterling, Dario Zocholl, et al.
Glia (2025)
Open Access
Cerebrospinal fluid interleukin-6 may be a biomarker for conversion of clinically isolated syndrome to neuromyelitis optica spectrum disorder
Yuzhen Wei, Huabing Wang, De‐Cai Tian, et al.
Multiple Sclerosis and Related Disorders (2025) Vol. 95, pp. 106313-106313
Closed Access
Proportions of Th17 cells and Th17-related cytokines in neuromyelitis optica spectrum disorders patients: A meta-analysis
Miaomiao Hou, Yufeng Li, Lingling He, et al.
International Immunopharmacology (2019) Vol. 75, pp. 105793-105793
Closed Access | Times Cited: 32
Downregulation of lncRNA XIST may promote Th17 differentiation through KDM6A-TSAd pathway in neuromyelitis optica spectrum disorders
Ruoyi Guo, Shuang Song, Jue-Qiong Wang, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 76, pp. 104801-104801
Closed Access | Times Cited: 10
Serum levels of IL-6 and IL-17 in multiple sclerosis, neuromyelitis optica patients and healthy subjects.
Fereshte Ashtari, Reyhanehsadat Madanian, Vahid Shaygannejad, et al.
PubMed (2019) Vol. 11, Iss. 6, pp. 267-273
Closed Access | Times Cited: 25
Anti-IL-6 Therapies for Neuromyelitis Optica Spectrum Disorders: A Systematic Review of Safety and Efficacy
Itay Lotan, Richard McGowan, Michael Levy
Current Neuropharmacology (2020) Vol. 19, Iss. 2, pp. 220-232
Open Access | Times Cited: 22
Cytokine and Chemokine Profiles in Patients with Neuromyelitis Optica Spectrum Disorder
Yuge Wang, Yifan Zhou, Xiaobo Sun, et al.
NeuroImmunoModulation (2016) Vol. 23, Iss. 5-6, pp. 352-358
Closed Access | Times Cited: 22
Low Serum Interleukin-10 Is an Independent Predictive Factor for the Risk of Second Event in Clinically Isolated Syndromes
Yuzhen Wei, Haoxiao Chang, Hao Feng, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 22
Expansion of IL-6+ Th17-like cells expressing TLRs correlates with microbial translocation and neurological disabilities in NMOSD patients
Priscila O. Barros, Aleida Dias, Taissa M. Kasahara, et al.
Journal of Neuroimmunology (2017) Vol. 307, pp. 82-90
Closed Access | Times Cited: 18
Elevated serum level of IL-4 in neuromyelitis optica and multiple sclerosis patients
Soheil Tahani, Leila Dehghani, Hamidreza Jahanbani‐Ardakani, et al.
Journal of Immunoassay and Immunochemistry (2019) Vol. 40, Iss. 5, pp. 555-563
Closed Access | Times Cited: 17
Maternal immune dysregulation and autism spectrum disorder
Alexandra Ramirez-Celis, Danielle Kim, Judy Van de Water
Elsevier eBooks (2023), pp. 21-61
Closed Access | Times Cited: 5
Interleukin-6, S-Nitrosothiols, and Neurodegeneration in Different Central Nervous System Demyelinating Disorders: Is There a Relationship?
Vera Fominykh, A. A. Vorobyeva, М. В. Онуфриев, et al.
Journal of Clinical Neurology (2018) Vol. 14, Iss. 3, pp. 327-327
Open Access | Times Cited: 13
The poor recovery of neuromyelitis optica spectrum disorder is associated with a lower level of CXCL12 in the human brain
Hao Kang, Shanshan Cao, Tingjun Chen, et al.
Journal of Neuroimmunology (2015) Vol. 289, pp. 56-61
Closed Access | Times Cited: 12
Blood‐based inflammatory protein biomarker panel for the prediction of relapse and severity in patients with neuromyelitis optica spectrum disorder: A prospective cohort study
Q. Wei, Jiahong Li, Chenyang Zhao, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 6
Open Access | Times Cited: 1
Metabolomic Profiling in Neuromyelitis Optica Spectrum Disorder Biomarker Discovery
Maxton E. Thoman, Susan C. McKarns
Metabolites (2020) Vol. 10, Iss. 9, pp. 374-374
Open Access | Times Cited: 9
Collection and Analyses of Cerebrospinal Fluid for Pediatric Translational Research
Saoirse Cameron, Carolina Gillio‐Meina, Adrianna Ranger, et al.
Pediatric Neurology (2019) Vol. 98, pp. 3-17
Closed Access | Times Cited: 8
Free thyroxine level is associated with both relapse rate and poor neurofunction in first-attack Neuromyelitis Optica Spectrum Disorder (NMOSD) patients
Qianyi He, Lifeng Li, Yanfei Li, et al.
BMC Neurology (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 8
Differentiation of remitting neuromyelitis optica spectrum disorders from multiple sclerosis by integrating parameters from serum proteins and lymphocyte subsets
Peng-Peng Ip, Chen-Yen Chung, Chien-Ching Chang, et al.
Journal of Neuroimmunology (2018) Vol. 318, pp. 45-52
Closed Access | Times Cited: 7
Neuromyelitis optica spectrum disorders in South of Tunisia: A rare entity with low seroprevalence of anti-aquaporin 4 autoantibodies
Sabrina Mejdoub, S. Feki, M. Dammak, et al.
Revue Neurologique (2019) Vol. 176, Iss. 4, pp. 261-267
Closed Access | Times Cited: 7
Elevation of AQP4 and selective cytokines in experimental autoimmune encephalitis mice provides some potential biomarkers in optic neuritis and demyelinating diseases.
Li Sun, Huan Weng, Zhenxin Li
PubMed (2015) Vol. 8, Iss. 12, pp. 15749-58
Closed Access | Times Cited: 5
Prognostic Factors for Recovery of Vision in Canine Optic Neuritis of Unknown Etiology: 26 Dogs (2003–2018)
Christoforos Posporis, Elsa Beltrán, Mark Dunning, et al.
Frontiers in Veterinary Science (2019) Vol. 6
Open Access | Times Cited: 5
NMO Spectrum Disorders
Steffen Pfeuffer, Christine Strippel, Heinz Wiendl
Neurology International Open (2017) Vol. 01, Iss. 01, pp. E36-E47
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top